Verrica Pharmaceuticals Inc. SEC filings VRCA
Verrica Pharmaceuticals Inc. has 534 filings in SEC EDGAR's recent list, going back to Dec 17, 2015. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Dec 23, 2025 | — |
| CORRESP | Letter to the SEC | Dec 19, 2025 | — |
| D | Filing | Dec 10, 2025 | — |
| DEFR14A | Filing | Apr 30, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| CORRESP | Letter to the SEC | Mar 21, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 17, 2025 | — |
| EFFECT | Filing | Dec 19, 2022 | — |
| CORRESP | Letter to the SEC | Dec 15, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 29, 2022 | — |
| CORRESP | Letter to the SEC | Nov 18, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 8, 2022 | — |
| SEC STAFF LETTER | Filing | Apr 19, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 22, 2021 | — |
| EFFECT | Filing | Mar 25, 2020 | — |
| CORRESP | Letter to the SEC | Mar 23, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 23, 2020 | — |
| CT ORDER | Filing | Dec 17, 2018 | — |
| EFFECT | Filing | Jun 14, 2018 | — |
| CERT | Filing | Jun 14, 2018 | — |
| 8-A12B | Filing | Jun 13, 2018 | — |
| CORRESP | Letter to the SEC | Jun 12, 2018 | — |
| CORRESP | Letter to the SEC | Jun 12, 2018 | — |
| UPLOAD | Letter from the SEC | Jun 8, 2018 | — |
| CORRESP | Letter to the SEC | Jun 5, 2018 | — |
| CORRESP | Letter to the SEC | May 29, 2018 | — |
| DRSLTR | Filing | May 2, 2018 | — |
| DRS/A | Filing | May 2, 2018 | — |
| UPLOAD | Letter from the SEC | Apr 26, 2018 | — |
| DRS | Filing | Mar 30, 2018 | — |
| D | Filing | Feb 21, 2018 | — |
| D | Filing | Dec 22, 2017 | — |
| D | Filing | Dec 17, 2015 | — |
Showing 34 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VRCA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- West Chester, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1660334
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.